Several clinical trials are now under way examining GLP-1 medications in MS and other neurodegenerative diseases such as Alzheimers and Parkinsons disease
Before you schedule a visit with us, we encourage you to learn as much as you can about GLP-1 receptor agonists, including their pros and cons
They can help determine the cause and find a solution, which might involve adjusting your dose or trying a different medication
Willard FS, Douros JD, Gabe MB, Showalter AD, Wainscott DB, Suter TM, Capozzi ME, van der Velden WJ, Stutsman C, Cardona GR, Urva S, Emmerson PJ, Holst JJ, DAlessio DA, Coghlan MP, Rosenkilde MM, Campbell JE, Sloop KW
Convenience: Pills are easy to carry and consume, while liquids may require measuring and can be less portable